How big is Rocket Pharmaceuticals, Inc.?

Jun 22 2025 06:13 PM IST
share
Share Via
As of Jun 18, Rocket Pharmaceuticals, Inc. has a market capitalization of 293.05 million and reported net sales of 0.00 million with a net profit of -258.03 million over the latest four quarters. Shareholder's funds are 463.23 million, and total assets amount to 527.70 million.
As of Jun 18, Rocket Pharmaceuticals, Inc. has a market capitalization of 293.05 million, categorizing it as a Small Cap company.

As of Jun 18, the sum of net sales for the latest four quarters is 0.00 million, while the sum of net profit for the same period is -258.03 million.

As of Dec 24, the reporting period shows shareholder's funds of 463.23 million and total assets of 527.70 million.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
What does Rocket Pharmaceuticals, Inc. do?
Jun 22 2025 07:00 PM IST
share
Share Via